✦ LIBER ✦

Pneumatic tube “pseudo tumor lysis syndrome” in chronic lymphocytic leukemia

✍ Scribed by Neha R. Chawla; Joel Shapiro; Ronald L. Sham

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 259 KB
Volume: 84
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.21473

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor lysis syndrome in a case of chroni

Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroids

✍ Coutinho, Anelisa K.; Santos, Marcelo de O.; Pinczowski, Hélio; Feher, Olavo; de 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

To the Editor: Schwachman's syndrome, a familial disease transmitted as an autosomal-recessive trait, is characterized by moderate chronic neutropenia, marked marrow hypocellularity, occasional thrombocytopenia and anemia, metaphyseal dysostosis of tubular bones, pancreatic fatty infiltration, and a

Acute tumor lysis syndrome secondary to

Acute tumor lysis syndrome secondary to hydroxycarbamide in chronic myelomonocytic leukemia

✍ Zaher K. Otrock; Ali T. Taher; Rami A.R. Mahfouz; Jawad A. Makarem; Ali I. Shams 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 1 views

Tumor lysis syndrome following VP-16-213

Tumor lysis syndrome following VP-16-213 in chronic myeloid leukemia in blast crisis

✍ M. Roy Thomas; W. A. Robinson; T. I. Mughal; L. Michael Glode 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 1 views

Tumor lysis syndrome (TLS) following flu

Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): Case report and review of the literature

✍ Kashif Hussain; Joseph J. Mazza; Lawrence H. Clouse 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 2 views

Tumor lysis syndrome occurring after the

Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: High-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia

✍ Yang, Honghao; Rosove, Michael H.; Figlin, Robert A. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB 👁 2 views

Rituximab, an anti-CD20 antibody, has been recently approved for the treatment of lowgrade or follicular non-Hodgkin's lymphoma (NHL). Because of its relatively benign side effect profile, it has been considered a nontoxic alternative to chemotherapy. Recently, however, tumor lysis syndrome (TLS) re